Deutsche Bank Ag\ Spring Works Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 56,198 shares of SWTX stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,198

Previous 60,714 7.44%

Holding current value

$2.61 Million

Previous $2.19 Million 13.09%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$32.5 - $59.93 $146,770 - $270,643	-4,516 Reduced 7.44%	56,198 $2.48 Million
Q4 2024 Feb 14, 2025	BUY	$28.61 - $42.55 $559,039 - $831,427	19,540 Added 47.46%	60,714 $2.19 Million
Q3 2024 Nov 13, 2024	BUY	$32.04 - $42.76 $307,712 - $410,667	9,604 Added 30.42%	41,174 $1.32 Million
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $132,268 - $174,670	-3,668 Reduced 10.41%	31,570 $1.19 Million
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $46,501 - $66,885	1,274 Added 3.75%	35,238 $1.73 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $62,369 - $122,631	3,293 Added 10.74%	33,964 $1.24 Million
Q3 2023 Nov 09, 2023	SELL	$23.12 - $31.38 $1.04 Million - $1.41 Million	-44,994 Reduced 59.46%	30,671 $709,000
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $462,467 - $653,447	19,977 Added 35.87%	75,665 $1.98 Million
Q1 2023 May 15, 2023	SELL	$24.97 - $34.05 $2.45 Million - $3.34 Million	-98,127 Reduced 63.8%	55,688 $1.43 Million
Q4 2022 Feb 13, 2023	BUY	$21.73 - $28.72 $1.02 Million - $1.35 Million	46,891 Added 43.85%	153,815 $4 Million
Q3 2022 Nov 14, 2022	SELL	$24.1 - $39.66 $9,326 - $15,348	-387 Reduced 0.36%	106,924 $3.05 Million
Q2 2022 Aug 11, 2022	BUY	$18.36 - $60.07 $41,713 - $136,479	2,272 Added 2.16%	107,311 $2.64 Million
Q1 2022 May 13, 2022	SELL	$48.97 - $65.46 $59,351 - $79,337	-1,212 Reduced 1.14%	105,039 $5.93 Million
Q4 2021 Feb 11, 2022	SELL	$53.3 - $75.84 $366,544 - $521,551	-6,877 Reduced 6.08%	106,251 $6.59 Million
Q3 2021 Nov 04, 2021	BUY	$62.66 - $88.26 $436,552 - $614,907	6,967 Added 6.56%	113,128 $7.18 Million
Q2 2021 Aug 11, 2021	BUY	$67.45 - $85.63 $2.61 Million - $3.31 Million	38,657 Added 57.27%	106,161 $8.75 Million
Q1 2021 May 13, 2021	BUY	$65.1 - $93.59 $3.16 Million - $4.55 Million	48,605 Added 257.18%	67,504 $4.97 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $310,809 - $500,791	6,427 Added 51.53%	18,899 $1.37 Million
Q3 2020 Nov 12, 2020	BUY	$36.14 - $51.99 $63,389 - $91,190	1,754 Added 16.36%	12,472 $594,000
Q2 2020 Aug 13, 2020	BUY	$22.98 - $48.57 $162,951 - $344,409	7,091 Added 195.51%	10,718 $451,000
Q1 2020 May 14, 2020	SELL	$20.44 - $41.21 $4,292 - $8,654	-210 Reduced 5.47%	3,627 $98,000
Q4 2019 Feb 14, 2020	BUY	$17.74 - $39.52 $68,068 - $151,638	3,837 New	3,837 $147,000

Others Institutions Holding SWTX

# of Institutions

361

Shares Held

63.1M

Call Options Held

5.81M

Put Options Held

2.55M

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.9B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account